Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer...
Vous n'êtes pas connecté
Optiscan’s latest study is now underway, using its InVue and InForm devices to help surgeons assess breast cancer margins in ...
Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer...
Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast cancer cells in early tests....
The Daily Item DANVILLE — Geisinger now offers 3D mammography systemwide, providing patients across its service area with access to the latest, best...
The Daily Item DANVILLE — Geisinger now offers 3D mammography systemwide, providing patients across its service area with access to the latest, best...
The message, from a stranger on Instagram, absolutely broke me. 'Dear Liz,' it began, 'I need to tell you about a friend with advanced breast cancer....
The message, from a stranger on Instagram, absolutely broke me. 'Dear Liz,' it began, 'I need to tell you about a friend with advanced breast cancer....
FRIDAY, June 20, 2025 -- Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy,...
FRIDAY, June 20, 2025 -- Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy,...
Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to its aggressive nature and...
An international...